Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 122 for “"Prime-boost"”.
-
Influenza Prime-Boost Vaccination, Diversity, And Evolution In Pigs
… was to explore the application of multiple prime-boost vaccination protocols to prevent influenza infections in pigs, and characterize the immune response, the within-host evolution of IAV, and the emergence of novel reassortant influenza viruses in vaccinated pigs compared to unvaccinated …
-
Prime boost vaccination with viral vectors targeting apical membrane antigen1
… MVA encoding AMA1 when used in a heterologous prime boost regime showed excellent immunogenicity, both humoral and cellular. The vaccination regime was protective against blood stage challenge and both antibodies and CD4+ T cells found to be important for vaccine induced blood stage protection. …
-
Determination of optimal prime-boost vaccination regimens against zaire ebolavirus
… four vaccination platforms, in a heterologous prime-boost regimen, increase survival and the breadth of the immune response. To test this hypothesis, the main objectives were to evaluate the cell-mediated and humoral immune responses, as well as correlate the induced immunity to protection …
-
Development of a Novel Prime-Boost Immunotherapy for Dedifferentiated Liposarcoma
… a proof-of-concept study, evaluating a novel prime-boost vaccine combination employing anti-DEC205 and oncolytic rhabdoviruses targeting a model antigen in a pre- clinical model of melanoma. This study showed that using the DEC205 dendritic cell-targeting antibody as a vector for antigen …
-
Developing a personalized heterologous prime boost vaccination strategy for tumor therapy
… study, a novel intravenous (IV) heterologous prime-boost vaccination strategy with a self-assembling neoantigen-peptide nanoparticle TLR-7/8 agonist (SNP) vaccine platform and a chimp adenovirus (ChAdOx1) was used to elicit high magnitude neoantigen-specific CD8 T cells and modulate the TME. …
-
Evaluation of mucosal T cell immunity following HIV-1 prime-boost immunization
… CD8{u207A} T cell responses following prime-boost immunization with a novel HIV-1 vaccine that encodes an IL-13 inhibitor (IL-13R{u03B1}2). Vaccination with this IL-13R{u03B1}2 vaccine has been shown previously to elicit high systemic HIV-specific CD8{u207A} T cell response with great T …
-
Bayesian inference for vaccine efficacy and prediction of survival probability in prime-boost vaccination regimes.
… for the next Ebola outbreak under a heterologous prime-boost vaccine regimen. The first level models the relationship between dose and induced antibody count. We use a two-stage response surface to model this relationship. The second level models the association between the antibody count and the …
-
Heterologous Prime-Boost strategies using live-attenuated and viral vector vaccines to combat pneumonic plague
Mice immunized with a 2-dose strategy utilizing either 2-doses of an adenovirus vector (Ad5-YFV) or a heterologous strategy utilizing Ad5-YFV and a live-attenuated (LMA) vaccine were evaluated for protective efficacy against pneumonic plague. A single immunization event giving both Ad5-YFV and LMA …
-
Developing an Oncolytic Prime-Boost Vaccine Targeting the Tumour Associated Antigen Mesothelin for the Treatment of Pancreatic Cancer
… that the use of neoadjuvant administration of a prime-boost oncolytic vaccine targeting a pancreatic tumour associated antigen (TAA) - mesothelin - could potentiate pancreatic tumour specific immune responses to improve patient prognosis. We demonstrate that immune tolerance to this self antigen …
-
Avaliação do potencial imunogênico e protetor da vacina contra Doença de Chagas pela estratégia “prime-boost” heterólogo DNA/rNTPDase-1
… pela vacinação utilizando a estratégia vacinal “prime-boost” heterólogo DNA/NTPDase-1 de T. cruzi, em camundongos BALB/c. Os resultados indicaram que a imunização com o “prime-boost”, induziu produção de níveis semelhantes tanto de IgG1 quanto de IgG2a, e embora o grupo imunizado com três doses …
-
Characterisation of heterologous prime-boost vaccination strategies : an investigation into the nature and delivery of vaccines and the subsequent generation of immune responses
… using a gene gun, followed by heterologous boosts, based on the same antigen delivered using an alternative route. These boost strategies included a) intramuscular delivery of purified recombinant HBcAg, b) mucosal delivery of HBcAg expressed by an attenuated strain of Salmonella …
-
Development Of Novel Vaccination Strategies Against Emerging Bunyaviruses
… rVSV-SFTSV vaccine in single dose, homologous prime-boost, and heterologous prime-boost regimens. We found that mRNA immunizations in single dose and homologous prime-boost regimens achieved the highest neutralizing antibody titers. Immunizations with rVSV-SFTSV also reached high antibody …
-
Biodegradable pulsatile release technologies for viral vector based vaccinations
… but they too often require a heterologous prime-boost approach such as the use of Adenoviral-MVA vectors. This thesis describes work utilising biodegradable microparticulate and non-microparticulate technologies to attempt to transform vaccination regimes from multiple into one single …
-
Development and pre-clinical evaluation of HIV-1 vaccines
… responses at birth and these responses can be boosted at adolescence, by a heterologous vector such as modified vaccinia Ankara (MVA) or Chimpanzee adenovirus serotype 63 (ChAdV63). In the first study, I assessed BCG-based vaccines derived from BCG Danish SSI-1331 (BCG<sub>1331</sub>), …
-
Induction Of Antibodies To Hiv-1 Envelope Using Simian Adenovirus Vaccines
… upon vaccination strategies: heterologous prime-boost regimens, immunogen design, and alternative adjuvants. To enhance Env-specific antibodies, I tested simian-derived adenovirus (SAdV) vectors expressing Env proteins and administered them in heterologous prime-boost regimens with …
-
HIV-1 vaccine development : evaluating mechanisms of CD8+ T cell avidity
… shown that mucosal HIV-1 recombinant pox viral prime-boost vaccination can induce HIV-specific CD8+ T cells with reduced interleukin (IL)-4 and IL-13 cytokine expression and higher avidity compared to systemic vaccine delivery. To understand how these cytokines regulated CD8+ T cell avidity, the …
-
The role of antigen in the maintenance and localisation of CD8+ T-cells in the context of liver stage malaria
… CD8<sup>+</sup> T-cells via heterologous prime-boost viral vector immunization, targeting primarily the pre- erythrocytic liver stages of the Plasmodium falciparum lifecycle. To date, the greatest immunogenicity has been obtained through a heterologous prime boost regimen, where …
-
INTERNALIZATION AND IMMUNOGENICITY OF MUCOSALLY-ADMINISTERED SOLUBLE AND PARTICULATE ANTIGENS
… an inferior immune memory, and understanding how prime-boost immunization regimens affect mucosal and systemic humoral immune memory remains an insufficiently explored area of research that is critical for vaccine development. In this work, we examined the routes of mucosal antigen internalization …
-
Evaluating aerosol administration of a candidate TB vaccine, MVA85A, as a way to induce potent local cellular immune responses and avoid anti-vector immunity
… protection against pulmonary TB. Heterologous prime-boost regimens with viral vector vaccines are a leading strategy for TB vaccine development. MVA85A is a viral vector candidate TB vaccine designed to boost BCG. This phase I clinical trial was designed to evaluate whether alternating aerosol …
-
Development and assessment of novel vaccination strategies for hepatitis B virus infection.
… nucleoside analogue, Entecavir (ETV), and “prime-boost” vaccination using DNA vaccines and recombinant fowl-pox virus (rFPV) strains that express DHBV surface or core alone. Previous “prime-boost” vaccination studies in the laboratory had used DNA vaccines and rFPV strains that expressed …
Page 1 of 7